Market Trends of Pressure Infusion Bags Industry
Blood and Drug Infusion is Expected to Show Lucrative Growth in the Pressure Infusion Bags Market Over the Forecast Period
Blood and drug infusions are carried out whenever any surgical procedure takes place that involves the loss of blood or the need for drug injection through infusion bags. As the prevalence of chronic diseases is rising worldwide, the treatment of various chronic diseases has been increasingly prioritized by the global health community or governments, even in low- and middle-income countries. As a result, the demand for rapid fluid transfusion has risen significantly in order to address the global disease burden, thus leading to a rise in the utilization and adoption of pressure infusion bags.
Hypovolemia is a condition that is commonly caused by dysfunction of various organs, such as congestive heart failure or kidney failure. If the hypovolemia is severe or persists over a long period of time, the compensatory changes in cardiac function may deteriorate into progressive cardiac failure. Hence, to avoid hypovolemia conditions in heart failure patients, pressure infusion bags are used, which is expected to increase the demand for the market studied.
According to the Heart and Circulatory Disease Statistics 2023, 936,556 patients were admitted to NHS hospitals in England for heart and circulatory diseases during 2021-2022. This was an increase from 807,074 patients in 2020-2021. Hence, the increase in cardiovascular disease admissions in hospitals is expected to increase the demand for blood and drug infusions, thereby contributing to the segment's growth over the forecast period.
Additionally, the increase in strategic activities by key players like blood and drug infusion IV bag launches, collaboration, and partnerships to increase the availability of pressure infusion bags across various regions are expected to bolster market growth over the forecast period. For instance, in June 2022, Gufic Biosciences launched dual-chamber IV bags for drug delivery in India. Gufic Biosciences collaborated with its French counterpart to manufacture the IV bag in India.
Hence, with the growing prevalence of chronic diseases such as cardiovascular diseases and cancer and strategic activities by the key players, the studied segment is expected to witness growth over the forecast period.
North America is Expected to Hold a Significant Share in the Pressure Infusion Bags Market Over the Forecast Period
North America is expected to hold a significant share of the pressure infusion bags market, primarily due to the high prevalence of chronic diseases, high healthcare expenditures, and the increase in surgical treatments for chronic diseases. In addition, the rapid advancements in pressure infusion systems are also expected to fuel market growth in the North American region.
According to the 2023 statistics published by the American Cancer Society, about 1.95 million new cancer cases are expected to be diagnosed in the United States in 2023, as compared to 1.91 million cases in 2022. Cancer treatment deprives the human body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, which increases the demand for delivering parenteral nutrition to patients. This is expected to fuel demand for pressure infusion bags, which are used to pressurize sterile parenteral fluids to patients, boosting market expansion.
Additionally, complex procedures, such as orthopedic replacements or thoracic surgery, performed in the country are expected to increase the demand for pressure infusion bags since intravenous medications are mostly given through pressure infusion bags. For instance, according to the data published by the Canadian Institute for Health Information in December 2022, about 700 outpatient hip and knee replacements were performed in Canada during 2021-2022. Thus, a high number of replacement procedures is expected to fuel market growth over the forecast period.
Furthermore, according to the data from the National Safety Council in 2021, an estimated 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment in the United States in 2021. The activities most frequently associated with injuries are exercise, cycling, and basketball. Therefore, the rise in the number of injuries associated with these types of activities is also expected to increase the adoption of pressure infusion bags.
Additionally, the increasing focus of the companies on adopting various key strategic initiatives such as acquisitions, partnerships, and other initiatives is expected to increase the number of infusion bags in the market, thereby propelling market growth. For instance, in January 2022, ICU Medical Inc. completed its acquisition of Smiths Medical from Smiths Group PLC. The Smiths Medical business includes syringes and ambulatory infusion devices (including pressure infusion bags), vascular access, and vital care products.
Hence, all the aforementioned factors, such as the increasing number of chronic diseases and their requirement for surgeries, coupled with strategic acquisitions by the key players, are expected to boost the growth of the market in the North America Region.
